Related Experiment Video
Updated: Aug 2, 2026
10:47
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Discussion on smoke and mucociliary transport
European Journal of Respiratory Diseases. Supplement
|January 1, 1985
Summary
Tobacco smoke acutely inhibits cilia, but key components and mechanisms remain unclear. This study identifies specific compounds affecting ciliary function and mucus transport, highlighting sulfhydryl group blockage as a potential mechanism.
Area of Science:
- Toxicology
- Respiratory Physiology
- Cell Biology
Background:
- Tobacco smoke is known to acutely inhibit ciliary function.
- The specific components responsible for this cilio-inhibitory effect are debated.
- Understanding these components is crucial for respiratory health research.
Purpose of the Study:
- To determine the relative importance of various tobacco smoke components in ciliary inhibition.
- To investigate the effect of ciliary inhibition on mucus transport rate.
- To explore the role of sulfhydryl group blockage in tobacco smoke-induced cilio-inhibition.
Main Methods:
- Analysis of gaseous and particulate phases of tobacco smoke.
- In vitro assessment of ciliary function and mucus transport.
- Evaluation of compound reversibility and dilution factors.
- Investigation of sulfhydryl group interactions.
Main Results:
- Identified specific compounds from both gaseous and particulate phases contributing to ciliary inhibition.
- Quantified the impact of ciliary inhibition on mucus transport.
- Demonstrated the reversibility of the observed cilio-inhibitory effects.
- Provided evidence for sulfhydryl group blockage as a mechanism.
Conclusions:
- Specific components of tobacco smoke, considering inhalation factors, significantly inhibit ciliary action.
- Ciliary inhibition directly impairs mucus clearance.
- Sulfhydryl group interaction is a key mechanism underlying tobacco smoke's effect on cilia.
Related Concept Videos
01:16The Respiratory System
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...